Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
American Journal of Physiology. Endocrinology and Metabolism
|
July 17, 2008
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality
Hwee Teoh, Adrian Quan, K W Annie Bang, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 9, 2025
Comparison of Myocardial Mechanics Post Mitral Valve Repair with Leaflet Preservation vs. Leaflet Resection: A Sub-Analysis of the Randomized CAMRA CardioLink-2 Trial
Rawan K Rumman, Subodh Verma, Vincent Chan, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 12, 2021
A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery
Mark D Peterson, Vinay Garg, C David Mazer, et al.
The Journal of Biological Chemistry
|
December 14, 2011
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
Krishna K Singh, Praphulla C Shukla, Adrian Quan, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
Subodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
JACC. Cardiovascular Imaging
|
January 17, 2021
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
Tamique Mason, Otavio R Coelho-Filho, Subodh Verma, et al.
The Annals of Thoracic Surgery
|
July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
Makoto Hibino, Arjun K Pandey, Vincent Chan, et al.
The Canadian Journal of Cardiology
|
March 8, 2013
Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?
Hwee Teoh, Jean-Pierre Després, Robert Dufour, et al.
Canadian Journal of Diabetes
|
September 28, 2013
Type 2 diabetes mellitus management in Canada: is it improving?
Lawrence A Leiter, Lori Berard, C Keith Bowering, et al.
Cell Metabolism
|
September 4, 2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
David A Hess, Daniella C Terenzi, Justin Z Trac, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
American Journal of Physiology. Endocrinology and Metabolism
|
July 17, 2008
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality
Hwee Teoh, Adrian Quan, K W Annie Bang, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 9, 2025
Comparison of Myocardial Mechanics Post Mitral Valve Repair with Leaflet Preservation vs. Leaflet Resection: A Sub-Analysis of the Randomized CAMRA CardioLink-2 Trial
Rawan K Rumman, Subodh Verma, Vincent Chan, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 12, 2021
A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery
Mark D Peterson, Vinay Garg, C David Mazer, et al.
The Journal of Biological Chemistry
|
December 14, 2011
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
Krishna K Singh, Praphulla C Shukla, Adrian Quan, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
Subodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
JACC. Cardiovascular Imaging
|
January 17, 2021
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
Tamique Mason, Otavio R Coelho-Filho, Subodh Verma, et al.
The Annals of Thoracic Surgery
|
July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
Makoto Hibino, Arjun K Pandey, Vincent Chan, et al.
The Canadian Journal of Cardiology
|
March 8, 2013
Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?
Hwee Teoh, Jean-Pierre Després, Robert Dufour, et al.
Canadian Journal of Diabetes
|
September 28, 2013
Type 2 diabetes mellitus management in Canada: is it improving?
Lawrence A Leiter, Lori Berard, C Keith Bowering, et al.
Cell Metabolism
|
September 4, 2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
David A Hess, Daniella C Terenzi, Justin Z Trac, et al.
Page
of 13